Pharmaceutical Business review

Meda wins approval for allergic conjunctivitis drug

The substance azelastine is an antihistamine and the eye drop formulation is approved for treatment of allergic conjunctivitis in adults and pediatrics.

Meda is conducting a broad development program for the azelastine substance, both as azelastine eye drops and azelastine nasal spray. Azelastine eye drops sample is one part of that development program.